Case guide
FDA warns that foam may break down in certain recalled devices. Discuss care and device checks without treating the warning as proof of your cancer cause.
Updated Oct 4, 202611 sources
See If You Qualify
Free · No obligation · About 2 minutes
Updated Oct 4, 202611 sources
This may apply to you if
These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.
Grégoire Justeau · Department of Respiratory and Sleep Medicine, Angers University Hospital, France · First-listed author of the original CPAP cancer cohort
Finding: The 4,447-person cohort found no increased overall cancer incidence among Philips users compared with other brands. Its observational design and follow-up cannot exclude every risk or decide an individual cause.
Justeau original CPAP cancer cohort, 2022 (opens in a new tab) · Jul 14, 2022 · Checked Oct 3, 2026
Pays de la Loire Sleep Cohort Study Group; Angers University Hospital, France · European Respiratory Journal · 2022
Read the source: Cancer risk in adherent users of polyurethane foam-containing CPAP devices for sleep apnoea (opens in a new tab) · Checked Oct 3, 2026
Food and Drug Administration · 2024
Read the source: FDA review of Philips foam testing; not a patient outcome study (opens in a new tab) · Checked Oct 3, 2026
The process
You answer a few questions
About two minutes. Nothing is sent until you agree on the last step and press submit.
A lawyer looks at it
A lawyer at the firm reads your answers and checks them against the current case criteria.
The firm decides and gets in touch
If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.
It is a foam used to reduce sound and vibration. FDA’s concern involves it in certain recalled Philips devices.
The full material name is polyester-based polyurethane. FDA says breakdown may release particles or some chemicals into the air tubes. This is a specific recall concern, not proof that every CPAP brand or every kind of foam has the same issue or that one person was exposed to a measured dose.
You may or may not see particles from the foam. Some chemicals of concern are not visible.
FDA explains that particles or some released chemicals could be breathed in or swallowed. Ask the clinician and supplier about concerns with the actual device; a clean-looking tube does not settle the recall question. Do not take the device apart to inspect or remove foam as a way to create claim evidence.
FDA warns of possible toxic and cancer-causing effects. It does not diagnose cancer or decide its cause in one user.
The agency’s potential-risk guidance is distinct from a patient study. A 4,447-person French cohort found no higher overall cancer rate for Philips than other-device users, with important limitations. Keep that counterevidence alongside the warning; neither source alone proves that every recalled machine is harmless or that a specific illness came from it.
The April 2024 page reports an October 2023 finding that more testing was needed. It does not announce a new 2026 test result.
FDA said testing and analysis shared by Philips were inadequate to fully assess the risks. The page maintains the agency’s potential-risk recommendations. A company testing summary, a court filing and a patient’s symptoms answer different questions; ask for the actual dated record rather than calling any one of them a personal cancer-cause determination.
Talk to your provider before changing device use. Do not add a CPAP or BiPAP filter, remove foam or use ozone or UV cleaners.
FDA notes stopping may be riskier for some patients and that ozone may worsen foam breakdown. Follow the manufacturer’s instructions rather than a claim page’s repair idea. Ask about the actual machine and alternatives; do not turn a recall concern into an unsupported decision about stopping prescribed breathing care.
Keep the model, serial number, use dates and care records. Ask a lawyer what harm and party evidence the claim needs.
Ask covered providers for missing medical or billing copies, with access exceptions in mind. Give counsel prior notices, releases and claim papers and seek a personal time-limit check. Get written legal fees and expense terms; no foam-warning discussion here confirms firm acceptance, a particular program or a recovery.
The review is free and private. Asking for it doesn’t commit you to anything.
Register your interestChecked against 9 primary sources by People's Justice editors · Updated
How we make moneyPeople's Justice research team · Updated Oct 4, 2026